Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management
COVID-19 pandemic is a serious concern in the new era. Acute respiratory distress
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
syndrome (ARDS), and lung failure are the main lung diseases in COVID-19 patients. Even …
An overview on the treatments and prevention against COVID-19
Y Panahi, AM Gorabi, S Talaei, F Beiraghdar… - Virology Journal, 2023 - Springer
Background The coronavirus disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to plague the world. While …
The molecular basis of COVID-19 pathogenesis, conventional and nanomedicine therapy
S Kouhpayeh, L Shariati, M Boshtam… - International journal of …, 2021 - mdpi.com
In late 2019, a new member of the Coronaviridae family, officially designated as “severe
acute respiratory syndrome coronavirus 2”(SARS-CoV-2), emerged and spread rapidly. The …
acute respiratory syndrome coronavirus 2”(SARS-CoV-2), emerged and spread rapidly. The …
All-solid-state paper-based potentiometric combined sensor modified with reduced graphene oxide (rGO) and molecularly imprinted polymer for monitoring losartan …
A cost-effective, highly selective and sensitive paper-based potentiometric combined sensor
for losartan potassium drug (LOS) is fabricated, characterized and used for the drug …
for losartan potassium drug (LOS) is fabricated, characterized and used for the drug …
Renin-angiotensin system pathway therapeutics associated with improved outcomes in males hospitalized with COVID-19
GLY Rocheleau, T Lee, Y Mohammed… - Critical Care …, 2022 - journals.lww.com
OBJECTIVES: To determine whether angiotensin receptor blockers (ARBs) or angiotensin-
converting enzyme (ACE) inhibitors are associated with improved outcomes in hospitalized …
converting enzyme (ACE) inhibitors are associated with improved outcomes in hospitalized …
Repurposing of chemotherapeutics to combat COVID-19
S Nandi, BS Nayak, MK Khede… - Current Topics in …, 2022 - benthamdirect.com
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is a novel strain of SARS
coronavirus. The COVID-19 disease caused by this virus was declared a pandemic by the …
coronavirus. The COVID-19 disease caused by this virus was declared a pandemic by the …
A multidisciplinary approach to coronavirus disease (COVID-19)
Since December 2019, humanity has faced an important global threat. Many studies have
been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus …
been published on the origin, structure, and mechanism of action of the SARS-CoV-2 virus …
Present and future treatment strategies for coronavirus disease 2019
E Elekhnawy, AA Kamar, F Sonbol - Future journal of pharmaceutical …, 2021 - Springer
Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in
many challenges to the healthcare organizations around the world. Unfortunately, until now …
many challenges to the healthcare organizations around the world. Unfortunately, until now …
Telmisartan nanosuspension for inhaled therapy of COVID-19 lung disease and other respiratory infections
Vaccine hesitancy and the occurrence of elusive variants necessitate further treatment
options for coronavirus disease 2019 (COVID-19). Accumulated evidence indicates that …
options for coronavirus disease 2019 (COVID-19). Accumulated evidence indicates that …
Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on …
M Valipour, S Di Giacomo, A Di Sotto… - International Journal of …, 2023 - mdpi.com
Previous studies indicated that natural-based chalcones have significant inhibitory effects on
the coronavirus enzymes 3CLpro and PLpro as well as modulation of some host-based …
the coronavirus enzymes 3CLpro and PLpro as well as modulation of some host-based …